148 related articles for article (PubMed ID: 38366260)
1. Higher than expected incident cases of spinal bulbar muscular atrophy in western Canada.
Lamont R; King M; King A; Schellenberg K; Pfeffer G
Brain; 2024 May; 147(5):e43-e44. PubMed ID: 38366260
[No Abstract] [Full Text] [Related]
2. X-linked spinal and bulbar muscular atrophy (Kennedy's disease): the first case described in the Brazilian Amazon.
Alves CN; Braga TKK; Somensi DN; Nascimento BSVD; Lima JAS; Fujihara S
Einstein (Sao Paulo); 2018 Jun; 16(2):eRC4011. PubMed ID: 29898093
[TBL] [Abstract][Full Text] [Related]
3. Onset Manifestations of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease).
Finsterer J; Soraru G
J Mol Neurosci; 2016 Mar; 58(3):321-9. PubMed ID: 26482145
[TBL] [Abstract][Full Text] [Related]
4. Split-hand sign: clinical feature of spinal bulbar muscular atrophy?
Vucic S
J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1143-1144. PubMed ID: 33004430
[No Abstract] [Full Text] [Related]
5. Spinal and Bulbar Muscular Atrophy Overview.
Fischbeck KH
J Mol Neurosci; 2016 Mar; 58(3):317-20. PubMed ID: 26547319
[TBL] [Abstract][Full Text] [Related]
6. Small nerves are a distinguishing feature of spinal and bulbar muscular atrophy (SBMA).
Pelosi L; Ghosh A; Leadbetter R; Rodrigues M; Roxburgh R
Neurol Sci; 2022 Jul; 43(7):4575-4576. PubMed ID: 35416572
[No Abstract] [Full Text] [Related]
7. Insights into the genetic epidemiology of spinal and bulbar muscular atrophy: prevalence estimation and multiple founder haplotypes in the Veneto Italian region.
Bertolin C; Querin G; Martinelli I; Pennuto M; Pegoraro E; Sorarù G
Eur J Neurol; 2019 Mar; 26(3):519-524. PubMed ID: 30351503
[TBL] [Abstract][Full Text] [Related]
8. Spinal and Bulbar Muscular Atrophy.
Grunseich C; Fischbeck KH
Neurol Clin; 2015 Nov; 33(4):847-54. PubMed ID: 26515625
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of spinal and bulbar muscular atrophy in South Korea: a cross-sectional study of 157 patients.
Cho HJ; Shin JH; Park YE; Sohn E; Nam TS; Kang MG; Park JM; Park D; Park JS
Brain; 2023 Mar; 146(3):1083-1092. PubMed ID: 35639850
[TBL] [Abstract][Full Text] [Related]
10. Dutasteride for spinal and bulbar muscular atrophy.
Banno H; Katsuno M; Suzuki K; Sobue G
Lancet Neurol; 2011 Feb; 10(2):113-5. PubMed ID: 21216198
[No Abstract] [Full Text] [Related]
11. Acetylcholinesterase inhibitor responsive myasthenia in a Filipino male with X-linked recessive spinal and bulbar muscular atrophy.
Jamora RDG; Prado MB; Chua CL
Neurol Sci; 2021 Oct; 42(10):4317-4320. PubMed ID: 34085109
[TBL] [Abstract][Full Text] [Related]
12. Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients.
Grunseich C; Zukosky K; Kats IR; Ghosh L; Harmison GG; Bott LC; Rinaldi C; Chen KL; Chen G; Boehm M; Fischbeck KH
Neurobiol Dis; 2014 Oct; 70():12-20. PubMed ID: 24925468
[TBL] [Abstract][Full Text] [Related]
13. In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy.
Pennuto M; Basso M
J Mol Neurosci; 2016 Mar; 58(3):365-73. PubMed ID: 26614347
[TBL] [Abstract][Full Text] [Related]
14. Advancing Epidemiology and Genetic Approaches for the Treatment of Spinal and Bulbar Muscular Atrophy: Focus on Prevalence in the Indigenous Population of Western Canada.
Wilton-Clark H; Al-Aghbari A; Yang J; Yokota T
Genes (Basel); 2023 Aug; 14(8):. PubMed ID: 37628685
[TBL] [Abstract][Full Text] [Related]
15. Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease.
Breza M; Koutsis G
J Neurol; 2019 Mar; 266(3):565-573. PubMed ID: 30006721
[TBL] [Abstract][Full Text] [Related]
16. Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial.
Grunseich C; Miller R; Swan T; Glass DJ; El Mouelhi M; Fornaro M; Petricoul O; Vostiar I; Roubenoff R; Meriggioli MN; Kokkinis A; Guber RD; Budron MS; Vissing J; Soraru G; Mozaffar T; Ludolph A; Kissel JT; Fischbeck KH;
Lancet Neurol; 2018 Dec; 17(12):1043-1052. PubMed ID: 30337273
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features of a genetically identified spinal and
bulbar muscular atrophy pedigree].
Wang Z; Chen Q; Li Q; Bi F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 41(10):1101-1105. PubMed ID: 27807335
[TBL] [Abstract][Full Text] [Related]
18. From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
Pennuto M; Rinaldi C
Mol Cell Endocrinol; 2018 Apr; 465():113-121. PubMed ID: 28688959
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Genotype-Phenotype Correlation of Korean Patients with Spinal and Bulbar Muscular Atrophy.
Song JS; Kim KA; Min JH; Ki CS; Kim JW; Sung DH; Kim BJ
Yonsei Med J; 2015 Jul; 56(4):993-7. PubMed ID: 26069122
[TBL] [Abstract][Full Text] [Related]
20. Correlation between the CAG repeat size and electrophysiological findings in patients with spinal and bulbar muscular atrophy.
Kim H; Lim YM; Lee EJ; Oh YJ; Kim KK
Muscle Nerve; 2018 Apr; 57(4):683-686. PubMed ID: 28972672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
